Overview

Tongxinluo Capsule in Ischemic Stroke Patients(TISS)

Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effects in improving life self-care ability of stroke patients after taking Tongxinluo Capsule(within 72 hours after onset) versus Placebos for 90 days.
Phase:
Phase 4
Details
Lead Sponsor:
yongjun wang